Susan T. Eitutis

Susan T. Eitutis

Auto-generated profile, based on publicly available information

Susan T. Eitutis

Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in Clinical Otolaryngology
Verified
Journal Article
Open access
SESusan T. Eitutis
Susan T. Eitutis
YTYu Chuen Tam
Yu Chuen Tam
Iwan Vaughan RobertsIwan Vaughan Roberts
Iwan Vaughan Roberts
CSChloe Swords
Chloe Swords
JTJames R. Tysome
James R. Tysome
MBManohar Bance
Manohar Bance
Objective: To investigate the value of scalp surface potentials to identify and manage partial short circuits to ground in cochlear implant electrodes.Design: A retrospective review of patients with suspected partial short circuits.Main outcome measure: Electrical output of individual electrodes was measured using scalp surface potentials for patients reporting a change in hearing function. Electrical output was compared to functional performance and impedance measurements to determine if devices with suspected partial short circuits were experiencing a decrease in performance as a result of reduced electrical output. Electrical output was checked in an artificial cochlea for two implants following explant surgery to confirm scalp surface potential results.Results: All patients with suspected partial short circuits (n = 49) had reduced electrical output, a drop in impedances to approximately ½ of previously stable measurements or to below 2 kΩ, an atypical electrical field measurement (EFI) and a decline in hearing function. Only devices with an atypical EFI showed reduced electrical output. Results of scalp based surface potentials could be replicated in an artificial cochlea following explantation of the device. All explant reports received to date (n = 42) have confirmed partial short circuits, with an additional four devices failing integrity tests.Conclusion: Surface potential measurements can detect partial shorts and had 100% correlation with atypical EFI measurements, which are characteristic of a partial short to ground in this device. Surface potentials can help determine the degree to which the electrode array is affected, particularly when behavioural testing is limited or not possible.


29 December 2019 in Cochlear Implants International
Verified
Journal Article
Closed access
MSM. K. Shrivastava
M. K. Shrivastava
SES. T. Eitutis
S. T. Eitutis
JLJ. W. Lee
J. W. Lee
PAP. R. Axon
P. R. Axon
NDN. P. Donnelly
N. P. Donnelly
MBManohar Bance
Manohar Bance
Objectives: To determine how patients who did not meet UK TA166 NICE criteria for cochlear implantation (CI) but were subsequently found to have cochlear dead regions (DRs) performed with CI. Methods: A retrospective review of medical records was performed on CI recipients: 152 controls and 40 in the DR group. Of these, 34 pairs were matched by pre-operative Bamford-Kowal-Bench (BKB) scores and compared. Results: The forty DR patients had a median age at implantation of 56 years. Their mean pre-operative BKB score of 23% increased to 78% after CI. Thirty-seven experienced improvements in BKB scores. In matched case-control analysis, the improvement in mean BKB score with CI was no different (p = 0.19) between the DR group and control group; a similar proportion of patients benefitted in each group. Discussion: This study is the largestreport to date of performance of patients with DRs, before and after CI. The DR group gain similar benefit as the controls. Conclusion: Patients with DRs, who did not meet TA166 NICE criteria, received the same benefit as those who did. TEN testing to detect DRs should be included in routine CI work-up where standard criteria are not met.

18 July 2023 in Applied Sciences
Verified
Journal Article
Open access
PDF file
DVDeborah Vickers
Deborah Vickers
JBJohn Briggs
John Briggs
WLWiebke Lamping
Wiebke Lamping
RARachel Andrew
Rachel Andrew
MBMina Bingham
Mina Bingham
VTVERS Clinical Support Team
VERS Clinical Support Team
Active bone-conducting hearing devices (aBCHD; e.g., MEDEL Bonebridge® (BB)) and active middle ear implants (aMEI; e.g., MEDEL Vibrant Soundbridge® (VSB)) use radio frequency transmission to send information from an external microphone and sound processor to an internally implanted transducer. These devices potentially have an advantage over devices with percutaneous links because the skin is closed over the implantable components, which should reduce the risk of skin problems and infection. On the other hand, surgical procedures are more complex, with a greater risk of damage due to surgery. The objectives of this research were to quantify the reliability and long-term survival of MEDEL VSB and BB devices, determine the adverse and serious adverse device-related complications, and consider associated causes. A multi-center observational retrospective and prospective study was conducted at eleven auditory implant centers in the United Kingdom. Data was collected using a surgical questionnaire and audiological reports. Data were obtained from patient notes or from prospective cases that had a minimum follow-up of one year post-implant. Consecutive patient records were reviewed. Datasets from 109 BB and 163 VSB were reviewed. Of these, 205 were retrospective case note reviews, and 67 were prospective cases. The mean follow-up was 4 and 6 years, respectively, for BB and VSB. Kaplan–Meier Survival analyses indicated that the BB survival was 97% and 93.3% at 1 and 5 years, respectively, and the VSB was 92.1% and 87% at the same time points. This is a large cohort study for the field and has indicated that BB and VSB are safe interventions. Care should be taken to monitor magnet strength in the first few months. For the majority of device-related effects, there was no apparent association with etiology. However, an interesting pattern emerged for individuals who exhibited an inflammatory response, e.g., adhesions or device extrusion, and those with a history of chronic suppurative otitis media. This should be considered in future work and is not surprising given that many VSB recipients have a complicated hearing history, often associated with otitis media.

14 August 2026 in Audiology Research
Verified
Journal Article
Open access
PDF file
MAMehrangiz Ashiri
Mehrangiz Ashiri
TSTony Spahr
Tony Spahr
CCChen Chen
Chen Chen
ABAzret Botash
Azret Botash
AMAshish Mehta
Ashish Mehta
KKKanthaiah Koka
Kanthaiah Koka
Objectives: Extracochlear electrodes (EEs), defined as electrode contacts located outside the cochlea, can degrade cochlear implant (CI) performance. We present and validate an Electric Field Imaging (EFI)-based algorithm that helps detect EEs and can be used intra- or post-operatively. Methods: An algorithm for detecting EEs from EFI data was developed. Validation and testing were performed using three datasets: (a) bench models with known EE conditions (saline and resistive load model), (b) clinical EFI recordings from CI recipients with imaging confirmation (CT or plain X-ray), and (c) EFI recordings without imaging. Primary outcomes included the ability to differentiate extracochlear conditions from fully inserted electrode arrays, as well as the concordance between the number of EE contacts identified by the algorithm and those determined from controlled bench configurations or available imaging data. Results: The algorithm reliably differentiated full insertion from EE conditions on bench models and clinical EFI recordings from CI recipients with imaging confirmation. In the imaging-confirmed clinical cohort (6 EE cases among 226 CI recipients), the algorithm achieved 100% sensitivity and specificity. In clinical cases without imaging, the algorithm flagged 3.94% as having extracochlear electrodes, within the range of prevalence reported in the literature. Furthermore, the lateral-wall electrode arrays were associated with a significantly higher extracochlear electrode occurrence compared to the pre-curved arrays. Conclusions: This EFI-based algorithm may provide a useful screening tool for EEs using routine clinical measurements, supporting intra-operative and post-operative detection while reducing reliance on imaging and thereby aiding clinical decision-making. The method can be integrated into existing clinical fitting software workflow and complements recent work on EFI-based tip fold-over detection. The observed sensitivity and specificity suggest that this approach may provide a valuable tool for identifying EEs in situations where imaging is unavailable or impractical.